EP0407569A1 - Diphenylethanes - Google Patents

Diphenylethanes

Info

Publication number
EP0407569A1
EP0407569A1 EP90903347A EP90903347A EP0407569A1 EP 0407569 A1 EP0407569 A1 EP 0407569A1 EP 90903347 A EP90903347 A EP 90903347A EP 90903347 A EP90903347 A EP 90903347A EP 0407569 A1 EP0407569 A1 EP 0407569A1
Authority
EP
European Patent Office
Prior art keywords
ethane
fluorobiphenyl
formula
phenylene
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP90903347A
Other languages
German (de)
French (fr)
Inventor
David Ian 6 Swallow Close Bishop
Stephen Lewis
David Coates
Simon 2 Blackbird Close Greenfield
Eike Poetsch
Volker Meyer
Klaus-Peter Stahl
Volker Reiffenrath
Herbert Plach
Reinhard Hittich
Andreas WÄCHTLER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3913164A external-priority patent/DE3913164C2/en
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of EP0407569A1 publication Critical patent/EP0407569A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/205Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C15/00Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts
    • C07C15/12Polycyclic non-condensed hydrocarbons
    • C07C15/18Polycyclic non-condensed hydrocarbons containing at least one group with formula
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C25/00Compounds containing at least one halogen atom bound to a six-membered aromatic ring
    • C07C25/18Polycyclic aromatic halogenated hydrocarbons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/14Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a carbon chain
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3028Cyclohexane rings in which at least two rings are linked by a carbon chain containing carbon to carbon single bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Definitions

  • Biphenylylethanes The invention relates to biphenylylethanes of the formula I, R 1 -CH 2 -X- (CH 2 CH 2 ) m -Ph-Ph-CH 2 CH 2 -Ph-Y-CH 2 -R 2 I wherein R 1 and R 2 each independently of the other alkyl,
  • Alkenyl or oxaalkyl with up to 12 carbon atoms one of the radicals R 1 and R 2 also H, m 0 or 1, X and Y each independently of one another O, S,
  • radical X also 1,4-phenylene or trans-1,4-cyclohexylene and radical Y also trans-1,4-cyclohexylene, and Ph 1,4 -Phenylene, one or two of the residues
  • the compounds of the formula I can be used as components of liquid-crystalline phases, in particular for displays which are based on the principle of the twisted cell, the guest-host effect, the effect of the deformation of aligned phases or the effect of dynamic scattering.
  • the object of the invention was to find new stable liquid-crystalline or mesogenic compounds with high birefringence, which are suitable as components of liquid-crystalline phases with low viscosity, high nematogenicity and favorable low-temperature behavior.
  • This object was achieved by the provision of the compounds of the formula I.
  • the compounds of the formula I are particularly suitable as components of liquid-crystalline phases.
  • they can be used to produce stable liquid-crystalline phases with a relatively large optical anisotropy and positive or negative dielectric anisotropy.
  • the substances of the formula I are particularly preferably suitable for use in mixtures for ECB effects.
  • the compounds of formula I have a wide range of uses. Depending on the choice of the substituents, these compounds can serve as base materials from which liquid-crystalline phases are predominantly composed; However, it is also possible to add compounds of the formula I to liquid-crystalline base materials from other classes of compounds in order, for example, to optimize the dielectric and / or optical anisotropy of such a dielectric.
  • the compounds of formula I are suitable also as intermediates for the manufacture of others
  • the compounds of the formula I are colorless in the pure state and form liquid-crystalline mesophases in
  • the invention thus relates to the compounds of the formula I and the use of these compounds as
  • the invention furthermore relates to liquid-crystalline phases containing at least one compound of the formula I, and to liquid-crystal display elements which contain them
  • R 1 , R 2 , X, Y and Ph have the meaning given above and below, unless expressly stated otherwise.
  • R 1 and / or R 2 are alkyl radicals in which an (“oxaalkyl”) CH 2 group can also be replaced by O atoms, they can be straight-chain or branched.
  • They are preferably straight-chain, have 2, 3, 4, 5, 6 or 7 carbon atoms and are therefore preferably ethyl,
  • Solubility in the usual liquid-crystalline base materials can be important, but especially as chiral dopants if they are optically active.
  • Branched groups of this type usually contain no more than one chain branch.
  • formula I includes both the optical antipodes and racemates and mixtures thereof.
  • X and Y are O or the single bond, with the single bond being particularly preferred.
  • Compounds in which one of the radicals Ph is 2- or 3-fluoro-1,4-phenylene are particularly preferred.
  • the radicals R 1 -X and R 2 -Y are preferably straight-chain alkyl or alkoxy.
  • Preferred compounds of the formula I and their sub-formulas are those in which at least one of the radicals contained therein has one of the preferred meanings indicated.
  • Particularly preferred smaller groups of compounds according to the invention are those of the following sub-formulas:
  • R 1 and R 2 have the meaning given in claim 1, X is 0 or a single bond, one of the radicals
  • Ph 2- or 3-fluoro-1,4-phenylene and the other
  • Radical Ph denotes 1,4-phenylene, and biphenylylethanes of the formula Ha,
  • R 1 and R 2 have the meaning given in claim 1.
  • the compounds of the formula I are prepared by methods known per se, as described in the literature (for example in the standard works such as Houben-Weyl, Methods of Organic Chemistry, Georg-Thieme-Verlag, Stuttgart), and under reaction conditions that are known and suitable for the implementations mentioned.
  • the starting materials can also be formed in situ in such a way that they are not isolated from the reaction mixture, but instead are immediately passed on to the
  • the compounds of formula I can be prepared by using a compound of formula II or a corresponding ethyne compound
  • R 3 -X-Ph-Ph-CH CH-Ph-YR 4 II under the conditions known to the person catalytically hydrogenated.
  • X, Y and Ph have the above
  • R 3 and R 4 each mean
  • the compounds of the formula II are obtainable in a manner known per se by Wittig or by Heck coupling from corresponding styrene compounds with halogen aromatics, which are either known or can be prepared in complete analogy to known compounds.
  • Ethynes of the formula II can also be prepared via the coupling of alkynyl-zinc compounds with aryl halides analogously to that of A.O. King, E. Negishi, F.J. Villani and A. Silveira in J. Org. Chem. 43 (1978) 358.
  • Ethynes of the formula II can also be prepared via the Fritsch-Buttenberg-Wiechell rearrangement (Ann. 279, 319, 327, 332, 1984), in which 1,1-diaryl-2-halogenethylenes are rearranged to diarylacetylenes in the presence of strong bases .
  • Ethynes of the formula II can also be prepared from 4-substituted phenyl- or cyclohexylacetylenes and aryl halides in the presence of a palladium catalyst, for example bis (triphenylphosphine) palladium (II) chloride, and copper (I) iodide (described in Synthesis (1980) 627 or Tetrahedron Letters 27 (1986) 1171).
  • the liquid-crystalline phases according to the invention consist of 2 to 15, preferably 3 to 12 components, including at least one compound of the formula I.
  • the other constituents are preferably selected from the nematic or nematogenic substances, in particular the known substances, from the classes of the azoxybenzenes, benzylidene anilines, Biphenyls, terphenyls, phenyl or cyclohexyl benzoates, cyclohexane-carboxylic acid phenyl or cyclohexyl esters, phenylcyclohexanes, cyclohexyl biphenyls, Cyclohexylcyclohexanes, cyclohexylnaphthalenes, 1,4-biscyclohexylbenzenes, 4,4'-biscyclohexylbiphenyls, phenyl or cyclophexylpyrimidines, phenyl- or cyclohexyld
  • R 6 -LGER 7 IV in which L and E each have a carbocyclic or heterocyclic ring system consisting of 1,4-disubstituted benzene and cyclohexane rings, 4,4'-disubstituted biphenyl, phenylcyclohexane and cyclohexylcyclohexane systems, 2,5-disubstituted pyrimidine - and 1,3-dioxane rings, 2, 6-disubstituted naphthalene, di- and tetrahydronaphthalene,
  • Y halogen preferably chlorine, or -CN
  • R 6 and R 7 denote alkyl, alkoxy, alkanoyloxy or alkoxycarbonyloxy having up to 18, preferably up to 8 carbon atoms, or one of these radicals by CN, NC, NO 2 , CF 3 , F, Cl or Br.
  • R 6 and R 7 are different from one another, one of these radicals usually being an alkyl or alkoxy group.
  • Other variants of the proposed substituents are also common. Many such substances or mixtures thereof are commercially available. All of these substances are obtainable by methods known from the literature.
  • the phases according to the invention contain about 0.1 to 99%, preferably 10 to 95%, of one or more compounds of the formula I. Also preferred are liquid-crystalline phases according to the invention, containing 0.1-40, preferably 0.5-30% of one or more compounds of Formula I.
  • the compounds of the formula I can also be used as components of smectic or chirally switched smectic liquid-crystalline phases. These phases are preferably chiral-chopped smectic liquid-crystalline phases, the achiral base mixture of which contains, in addition to compounds of the formula I, at least one other component with negative or small positive dielectric anisotropy. This further component (s) of the achiral base mixture can make up 1 to 50%, preferably 10 to 25%, of the base mixture.
  • the phases according to the invention are produced in a conventional manner.
  • the components are dissolved in one another, expediently at elevated temperature.
  • the liquid-crystalline phases according to the invention can be modified so that they can be used in all types of liquid-crystal display elements which have hitherto become known.
  • Such additives are known to the person skilled in the art and are described in detail in the literature.
  • conductive salts preferably ethyl dimethyl dodecyl ammonium 4-hexyloxybenzoate, tetrabutylammonium tetraphenylboranate or complex salts of crown ethers (see, for example, I. Haller et al., Mol. Cryst. Liq. Cryst. Volume 24, pages 249-258
  • dichroic dyes for producing colored guest-host systems or substances for changing the dielectric anisotropy, the viscosity and / or the orientation of the nematic phases are added.
  • dichroic dyes for producing colored guest-host systems or substances for changing the dielectric anisotropy, the viscosity and / or the orientation of the nematic phases are added.
  • Such substances are e.g. in DE-OS 22 09 127, 22 40 864, 23 21 632, 23 38 281, 24 50 088, 26 37 430, 28 53 728 and 29 02 177.

Abstract

Des biphénylyléthanes ont la formule (I): R1-CH2-X-(CH2CH2)m-Ph-Ph-CH2CH2-Ph-Y-CH2-R2, dans laquelle R1 et R2 représentent indépendamment l'un de l'autre alkyle, alkényle ou oxaalkyle ayant jusqu'à 12 atomes de C, un des résidus R1 et R2 pouvant également représenter H; m est égal à 0 ou 1; X et Y représentent indépendamment l'un de l'autre O, S, CO-O, O-CO, O-CO-O ou une liaison simple, le résidu X pouvant également représenter 1,4-phénylène ou trans-1,4-cyclohexylène et le résidu Y également trans-1,4-cyclohexylène, et Ph représente 1,4-phénylène, un ou deux résidus Ph pouvant également représenter 2- ou 3-fluor-1,4-phénylène, à condition que dans le cas (a), où X = 1,4-phénylène et m = 1, un ou deux résidus Ph représentent 2- ou 3-fluor-1,4-phénylène et que dans le cas (b), où X = trans-1,4-cyclohexylène , m = 0 et un ou deux résidus Ph représentent 2- ou 3-fluor-1,4-phénylène. Ces composés sont utiles comme composants de phases de cristaux liquides.Biphenylylethanes have the formula (I): R1-CH2-X- (CH2CH2) m-Ph-Ph-CH2CH2-Ph-Y-CH2-R2, in which R1 and R2 independently represent one another, alkenyl or oxaalkyl having up to 12 C atoms, one of the residues R1 and R2 also being able to represent H; m is 0 or 1; X and Y independently of one another represent O, S, CO-O, O-CO, O-CO-O or a single bond, the residue X can also represent 1,4-phenylene or trans-1, 4-cyclohexylene and residue Y also trans-1,4-cyclohexylene, and Ph represents 1,4-phenylene, one or two residues Ph can also represent 2- or 3-fluor-1,4-phenylene, provided that in the case (a), where X = 1,4-phenylene and m = 1, one or two residues Ph represent 2- or 3-fluor-1,4-phenylene and that in the case (b), where X = trans -1,4-cyclohexylene, m = 0 and one or two residues Ph represent 2- or 3-fluor-1,4-phenylene. These compounds are useful as components of liquid crystal phases.

Description

Biphenylylethane Die Erfindung betrifft Biphenylylethane der Formel I, R1-CH2-X-(CH2CH2)m-Ph-Ph-CH2CH2-Ph-Y-CH2-R2 I worin R 1 und R2 jeweils unabhängig voneinander Alkyl, Biphenylylethanes The invention relates to biphenylylethanes of the formula I, R 1 -CH 2 -X- (CH 2 CH 2 ) m -Ph-Ph-CH 2 CH 2 -Ph-Y-CH 2 -R 2 I wherein R 1 and R 2 each independently of the other alkyl,
Alkenyl oder Oxaalkyl mit bis zu 12 C-Atomen, einer der Reste R 1 und R2 auch H, m 0 oder 1, X und Y jeweils unabhängig voneinander O, S, Alkenyl or oxaalkyl with up to 12 carbon atoms, one of the radicals R 1 and R 2 also H, m 0 or 1, X and Y each independently of one another O, S,
CO-O, O-CO, O-CO-O oder eine Einfachbindung, Rest X auch 1,4-Phenylen oder trans-1,4-Cyclohexylen und Rest Y auch trans-1,4-Cyclohexylen, und Ph 1,4-Phenylen, einer oder zwei der Reste  CO-O, O-CO, O-CO-O or a single bond, radical X also 1,4-phenylene or trans-1,4-cyclohexylene and radical Y also trans-1,4-cyclohexylene, and Ph 1,4 -Phenylene, one or two of the residues
Ph auch 2- oder 3-Fluor-1,4-phenylen, bedeutet, mit der Maßgabe daß im Falle (a) X = 1,4-Phenylen und m = 1 einer oder zwei der Reste Ph 2- oder 3-Fluor-1,4-phenylen bedeuten und (b) im Falle X = trans-1,4-Cyclohexylen, m = 0 und einer oder zwei der Reste Ph 2- oder 3-Fluor-1,4-phenylen bedeuten. Die Verbindungen der Formel I können als Komponenten flüssigkristalliner Phasen verwendet werden, insbesondere für Displays, die auf dem Prinzip der verdrillten Zelle, dem Guest-Host-Effekt, dem Effekt der Deformation aufgerichteter Phasen oder dem Effekt der dynamischen Streuung beruhen. Ph also means 2- or 3-fluoro-1,4-phenylene, with the proviso that in case (a) X = 1,4-phenylene and m = 1 one or two of the residues Ph 2- or 3-fluoro- Mean 1,4-phenylene and (b) in the case of X = trans-1,4-cyclohexylene, m = 0 and one or two of the radicals Ph mean 2- or 3-fluoro-1,4-phenylene. The compounds of the formula I can be used as components of liquid-crystalline phases, in particular for displays which are based on the principle of the twisted cell, the guest-host effect, the effect of the deformation of aligned phases or the effect of dynamic scattering.
Verbindungen der Formel I sind vorzugsweise auch geeignet für die Verwendung als Komponenten in flüssigkristallinen Phasen für Displays, die auf dem ECB-Effekt beruhen. Ähnliche flüssigkristalline Verbindungen sind z.B. ausCompounds of the formula I are preferably also suitable for use as components in liquid-crystalline phases for displays which are based on the ECB effect. Similar liquid crystalline compounds are e.g. out
USP 4,695,131 bekannt. Die dort beschriebenen Verbindungen weisen jedoch eine Cyclohexylethyl-Gruppierung auf. USP 4,695,131 known. However, the compounds described there have a cyclohexylethyl grouping.
Chirale Verbindungen für ferroelektrische Flüssigkristallmischungen der Formel Chiral compounds for ferroelectric liquid crystal mixtures of the formula
sind in JP 61-243037-A beschrieben. Darüberhinaus ist eine chirale Verbindung der Struktur  are described in JP 61-243037-A. In addition, there is a chiral connection of the structure
in der EP-OS 0 259 995 beschrieben.  in EP-OS 0 259 995.
Über eine Verbindung der Struktur Via a connection of the structure
bei der Synthese von Cyclophan-Verbindungen wird von H.A. Staab und M. Haenel berichtet (Chem. Ber., 106 (7), 2150-2202 (1973)). G.W. Gray et al. schließlich berichten in Liquid Crystals, 1986, Vol. 1, No. 5, S. 407-413, u.a. über Verbindungen der Formel HA Staab and M. Haenel have reported in the synthesis of cyclophane compounds (Chem. Ber., 106 (7), 2150-2202 (1973)). GW Gray et al. finally report in Liquid Crystals, 1986, Vol. 1, No. 5, pp. 407-413, inter alia via compounds of the formula
weisen in diesem Zusammenhang auf einen allgemein von der Flüssigkristallfachwelt akzeptierten negativen Effekt der Trennung der π-Systeme in diesem Zusammenhang hin. in this connection indicate a negative effect of the separation of the π systems in this connection that is generally accepted by the liquid crystal industry.
Der Erfindung lag die Aufgabe zugrunde, neue stabile flüssigkristalline oder mesogene Verbindungen mit hoher Doppelbrechung aufzufinden, die als Komponenten flüssigkristalliner Phasen mit niedriger Viskosität, hoher Nematogenitat und günstigem Tieftemperaturverhalten geeignet sind. Diese Aufgabe wurde durch die Bereitstellung der Verbindungen der Formel I gelöst. Es wurde gefunden, daß die Verbindungen der Formel I als Komponenten flüssigkristalliner Phasen vorzüglich geeignet sind. Insbesondere sind mit ihrer Hilfe stabile flüssigkristalline Phasen mit relativ großer optischer Anisotropie und positiver oder negativer dielektrischer Anisotropie herstellbar. Die Substanzen der Formel I sind beispielsweise besonders bevorzugt für die Verwendung in Mischungen für ECB-Effekte geeignet. The object of the invention was to find new stable liquid-crystalline or mesogenic compounds with high birefringence, which are suitable as components of liquid-crystalline phases with low viscosity, high nematogenicity and favorable low-temperature behavior. This object was achieved by the provision of the compounds of the formula I. It has been found that the compounds of the formula I are particularly suitable as components of liquid-crystalline phases. In particular, they can be used to produce stable liquid-crystalline phases with a relatively large optical anisotropy and positive or negative dielectric anisotropy. For example, the substances of the formula I are particularly preferably suitable for use in mixtures for ECB effects.
Der ECB-Effekt (electrically controlled birefringence) oder auch DAP-Effekt (Deformation aufgerichteter Phasen) wurde erstmals 1971 beschrieben (M.F. Schieckel und The ECB effect (electrically controlled birefringence) or DAP effect (deformation of erected phases) was first described in 1971 (M.F. Schieckel and
K. Fahrenschon, "Deformation of nematic liquid crystals with vertical orientation in electrical fields",  K. Fahrenschon, "Deformation of nematic liquid crystals with vertical orientation in electrical fields",
Appl.Phys.Lett. 19 (1971), 3912). Es folgten Arbeiten von J.F. Kahn (Appl.Phys.Lett. 2J) (1972), 1193) und Appl.Phys.Lett. 19 (1971), 3912). Works by J.F. Kahn (Appl.Phys.Lett. 2J) (1972), 1193) and
G. Labrunie und J. Robert (J.Appl.Phys. 44 (1973), 4869). Die Arbeiten von J. Robert und F. Clerc (SID 80 Digest Techn.Papers (1980), 30), J. Duchene (Displays 7 (1986), 3) und H. Schad (SID 82 Digest Techn. Papers (1982), 244) haben gezeigt, daß flüssigkristalline Phasen hohe Werte für das Verhältnis der elastischen Konstanten K3/K1, hohe Werte für die optische Anisotropie Δn und negative Werte für die dielektrische Anisotropie Δs aufweisen müssen, um für hochiiiformative Anzeigeelemente basierend auf dem ECB-Effekt eingesetzt werden zu können. Auf dem ECB-Effekt basierende elektrooptische Anzeigeelemente weisen eine homöotrope Randorientierung auf, d.h. die flüssigkristalline Phase hat eine negative dielektrische Anisotropie. G. Labrunie and J. Robert (J.Appl.Phys. 44 (1973), 4869). The work of J. Robert and F. Clerc (SID 80 Digest Techn.Papers (1980), 30), J. Duchene (Displays 7 (1986), 3) and H. Schad (SID 82 Digest Techn. Papers (1982) , 244) have shown that liquid-crystalline phases must have high values for the ratio of the elastic constants K 3 / K 1 , high values for the optical anisotropy Δn and negative values for the dielectric anisotropy Δs in order to be able to use highly Effect can be used. Electro-optical display elements based on the ECB effect have a homeotropic edge orientation, ie the liquid-crystalline phase has a negative dielectric anisotropy.
Überraschend zeigte sich, daß der Zusatz von Verbindungen der Formel I flüssigkristalline Phasen liefert, die alle oben genannten Kriterien hervorragend erfüllen. Surprisingly, it was found that the addition of compounds of the formula I gives liquid-crystalline phases which meet all of the criteria mentioned above excellently.
Mit der Bereitstellung der Verbindungen der Formel I wird außerdem ganz allgemein die Palette der flüssigkristallinen Substanzen, die sich unter verschiedenen anwendungstechnischen Gesichtspunkten zur Herstellung nematischer Gemische eignen, erheblich verbreitert. With the provision of the compounds of the formula I, the range of liquid-crystalline substances which are suitable for the preparation of nematic mixtures from various technical aspects is also very broadly widened.
Die Verbindungen der Formel I besitzen einen breiten Anwendungsbereich. In Abhängigkeit von der Auswahl der Substituenten können diese Verbindungen als Basismaterialien dienen, aus denen flüssigkristalline Phasen zum überwiegenden Teil zusammengesetzt sind; es können aber auch Verbindungen der Formel I flüssigkristallinen Basismaterialien aus anderen Verbindungsklassen zugesetzt werden, um beispielsweise die dielektrische und/oder optische Anisotropie eines solchen Dielektrikums zu optimieren. Die Verbindungen der Formel I eignen sich ferner als Zwischenprodukte zur Herstellung anderer The compounds of formula I have a wide range of uses. Depending on the choice of the substituents, these compounds can serve as base materials from which liquid-crystalline phases are predominantly composed; However, it is also possible to add compounds of the formula I to liquid-crystalline base materials from other classes of compounds in order, for example, to optimize the dielectric and / or optical anisotropy of such a dielectric. The compounds of formula I are suitable also as intermediates for the manufacture of others
Substanzen, die sich als Bestandteile flüssigkristalliner Phasen verwenden lassen. Substances that can be used as components of liquid crystalline phases.
Die Verbindungen der Formel I sind in reinem Zustand farblos und bilden flüssigkristalline Mesophasen in The compounds of the formula I are colorless in the pure state and form liquid-crystalline mesophases in
einem für die elektrooptische Verwendung günstig gelegenen Temperaturbereich. Chemisch, thermisch und gegen Licht sind sie sehr stabil. a temperature range conveniently located for electro-optical use. They are very stable chemically, thermally and against light.
Gegenstand der Erfindung sind somit die Verbindungen der Formel I sowie die Verwendung dieser Verbindungen als The invention thus relates to the compounds of the formula I and the use of these compounds as
Komponenten flüssigkristalliner Phasen. Weiterhin sind Gegenstand der Erfindung flüssigkristalline Phasen mit einem Gehalt an mindestens einer Verbindung der Formel I, sowie Flüssigkristall-Anzeigeelemente, die derartige Components of liquid crystalline phases. The invention furthermore relates to liquid-crystalline phases containing at least one compound of the formula I, and to liquid-crystal display elements which contain them
Phasen enthalten. Vor- und nachstehend haben R 1, R2, X, Y und Ph die angegebene Bedeutung, sofern nicht ausdrücklich etwas anderes vermerkt ist. Phases included. R 1 , R 2 , X, Y and Ph have the meaning given above and below, unless expressly stated otherwise.
Falls R 1 und/oder R2 Alkylreste bedeuten, in denen auch eine ("Oxaalkyl") CH2-Gruppe durch O-Atome ersetzt sein können, so können sie geradkettig oder verzweigt sein. If R 1 and / or R 2 are alkyl radicals in which an (“oxaalkyl”) CH 2 group can also be replaced by O atoms, they can be straight-chain or branched.
Vorzugsweise sind sie geradkettig, haben 2, 3, 4, 5, 6 oder 7 C-Atome und bedeuten demnach bevorzugt Ethyl, They are preferably straight-chain, have 2, 3, 4, 5, 6 or 7 carbon atoms and are therefore preferably ethyl,
Propyl, Butyl, Pentyl, Hexyl, Heptyl, 2-Oxapropyl Propyl, butyl, pentyl, hexyl, heptyl, 2-oxapropyl
(= Methoxyraethyl), 2- (= Ethoxymethyl) oder 3-Oxabutyl (= 2-Methoxyethyl), 2-, 3- oder 4-Oxapentyl, 2-, 3-, 4- oder 5-Oxahexyl, 2-, 3-, 4-, 5- oder 6-Oxaheptyl, ferner Methyl, Octyl, Nonyl, Decyl, Undecyl, Dodecyl, Tridecyl, Tetradecyl, Pentadecyl, 2-, 3-, 4-, 5-, 6- oder 7-Oxaoctyl, 2-, 3-, 4-, 5-, 6-, 7- oder 8-Oxanonyl, 2-, 3-, 4-, 5-,(= Methoxyraethyl), 2- (= ethoxymethyl) or 3-oxabutyl (= 2-methoxyethyl), 2-, 3- or 4-oxapentyl, 2-, 3-, 4- or 5-oxahexyl, 2-, 3- , 4-, 5- or 6-oxaheptyl, also methyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, 2-, 3-, 4-, 5-, 6- or 7-oxaoctyl, 2 -, 3-, 4-, 5-, 6-, 7- or 8-oxanonyl, 2-, 3-, 4-, 5-,
6-, 7-, 8- oder 9-Oxadecyl. Die Reste R 1-X und/oder R2-Y, in denen X bzw. Y O bedeutet, bedeuten somit einen Alkoxyoder Alkoxyalkoxyrest mit 2, 3, 4, 5, 6, 7 C-Atomen. 6-, 7-, 8- or 9-oxadecyl. The radicals R 1 -X and / or R 2 -Y, in which X and YO respectively mean an alkoxy or alkoxyalkoxy radical having 2, 3, 4, 5, 6, 7 carbon atoms.
Sie bedeuten demnach bevorzugt Ethoxy, Propoxy, Butoxy, Pentoxy, Hexoxy, Heptoxy, Methoxy, Octoxy, Nonoxy, Decoxy, Undecoxy, Dodecoxy, Tridecoxy, Tetradecoxy, Pentadecoxy, 1,3-Dioxabutyl (= Methoxymethoxy), 1,3-, 1,4- oder 2,4-Dioxapentyl, 1,3-, 1,4-, 1,5-, 2,4-, 2,5- oder 3,5-Dioxahexyl, 1,3-, 1,4-, 1,5-, 1,6-, 2,4-, 2,5-, 2,6-, 3,5-, 3,6- oder 4,6-Dioxaheptyl. Besonders bevorzugt sind auch Alkylreste in denen eine CH2-Gruppe durch eine -CH=CH-Gruppe oder durch -CHF-ersetzt ist. Accordingly, they preferably mean ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, methoxy, octoxy, nonoxy, decoxy, undecoxy, dodecoxy, tridecoxy, tetradecoxy, pentadecoxy, 1,3-dioxabutyl (= methoxymethoxy), 1,3-, 1 , 4- or 2,4-dioxapentyl, 1,3-, 1,4-, 1,5-, 2,4-, 2,5- or 3,5-dioxahexyl, 1,3-, 1,4- , 1,5-, 1,6-, 2,4-, 2,5-, 2,6-, 3,5-, 3,6- or 4,6-dioxaheptyl. Alkyl radicals in which a CH 2 group is replaced by a -CH = CH group or by -CHF- are also particularly preferred.
Verbindungen der Formel I mit verzweigten Flügelgruppen R 1 oder R2 können gelegentlich wegen einer besseren Compounds of formula I with branched wing groups R 1 or R 2 can occasionally because of a better
Löslichkeit in den üblichen flüssigkristallinen Basismaterialien von Bedeutung sein, insbesondere aber als chirale Dotierstoffe, wenn sie optisch aktiv sind. Solubility in the usual liquid-crystalline base materials can be important, but especially as chiral dopants if they are optically active.
Verzweigte Gruppen dieser Art enthalten in der Regel nicht mehr als eine Kettenverzweigung. Bevorzugte verzweigte Rest sind Isopropyl, 2-Butyl (= 1-Methylpropyl), Isobutyl (= 2-Methylpropyl), 2-Meth.ylbutyl, Isopentyl (= 3-Methylbutyl), 2-Methylpentyl, 3-Methylpentyl, 2-Ethylhexyl, Branched groups of this type usually contain no more than one chain branch. Preferred branched radicals are isopropyl, 2-butyl (= 1-methylpropyl), isobutyl (= 2-methylpropyl), 2-meth.ylbutyl, isopentyl (= 3-methylbutyl), 2-methylpentyl, 3-methylpentyl, 2-ethylhexyl,
2-Propylpentyl, 2-Octyl, Isopropoxy, 2-Methylpropoxy,  2-propylpentyl, 2-octyl, isopropoxy, 2-methylpropoxy,
2-Methylbutoxy, 3-Methylbutoxy, 2-Methylpentoxy, 3-Methylpentoxy, 2-Ethylhexoxy, 1-Methylhexoxy, 1-Methylheptoxy 2-methylbutoxy, 3-methylbutoxy, 2-methylpentoxy, 3-methylpentoxy, 2-ethylhexoxy, 1-methylhexoxy, 1-methylheptoxy
(= 2-Octyloxy), 2-Oxa-3-methylbutyl, 3-Oxa-4-methylpentyl, 4-Methylhexyl, 2-Nonyl, 2-Decyl, 2-Dodecyl, 6-Methyloctoxy, 6-Methyloctanoyloxy, 5-Methylheptyloxycarbonyl, 2-Methylbutyryloxy, 3-Methylvaleryloxy, 4-Methylhexanoyloxy, (= 2-octyloxy), 2-oxa-3-methylbutyl, 3-oxa-4-methylpentyl, 4-methylhexyl, 2-nonyl, 2-decyl, 2-dodecyl, 6-methyloctoxy, 6-methyloctanoyloxy, 5-methylheptyloxycarbonyl , 2-methylbutyryloxy, 3-methylvaleryloxy, 4-methylhexanoyloxy,
2-Methyl-3-oxapentyl, 2-Methyl-3-oxahexyl. Bei Verbindungen mit verzweigten Flügelgruppen umfaßt Formel I sowohl die optischen Antipoden als auch Racemate sowie deren Gemische. 2-methyl-3-oxapentyl, 2-methyl-3-oxahexyl. For compounds with branched wing groups, formula I includes both the optical antipodes and racemates and mixtures thereof.
Die bevorzugten Bedeutungen von X und Y sind O oder die Einfachbindung, wobei die Einfachbindung besonders bevorzugt ist. Besonders bevorzugt sind solche Verbindungen, worin einer der Reste Ph 2- oder 3-Fluor-1,4-phenylen ist. Die Reste R 1-X und R2-Y sind vorzugsweise geradkettiges Alkyl oder Alkoxy. Unter den Verbindungen der Formel I und deren Unterformeln sind diejenigen bevorzugt, in denen mindestens einer der darin enthaltenen Reste eine der angegebenen bevorzugten Bedeutungen hat. The preferred meanings of X and Y are O or the single bond, with the single bond being particularly preferred. Compounds in which one of the radicals Ph is 2- or 3-fluoro-1,4-phenylene are particularly preferred. The radicals R 1 -X and R 2 -Y are preferably straight-chain alkyl or alkoxy. Preferred compounds of the formula I and their sub-formulas are those in which at least one of the radicals contained therein has one of the preferred meanings indicated.
Besonders bevorzugte kleinere Gruppe von erfindungsgemäßen Verbindungen sind diejenigen der folgenden Teilformeln: Particularly preferred smaller groups of compounds according to the invention are those of the following sub-formulas:
- -
(0) bedeutet 0 oder eine Einfachbindung (0) means 0 or a single bond
R und R' bedeuten jeweils n-Alkyl mit bis zu 12 C-Atomen. R and R 'each denote n-alkyl having up to 12 carbon atoms.
Der Zentralteil der erfindungsgemäßen Verbindungen The central part of the compounds according to the invention
-Ph-Phe-CH2CH2-Ph- hat vorzugsweise eine der folgenden Bedeutungen: -Ph-Phe-CH 2 CH 2 -Ph- preferably has one of the following meanings:
Bedeutung 2 ist besonders bevorzugt. Meaning 2 is particularly preferred.
Besonders bevorzugt sind Biphenylylethane der Formel II, Biphenylylethanes of the formula II are particularly preferred,
worin R 1 und R2 die in Anspruch 1 angegebene Bedeutung haben, X 0 oder eine Einfachbindung ist, einer der Restewherein R 1 and R 2 have the meaning given in claim 1, X is 0 or a single bond, one of the radicals
Ph 2- oder 3-Fluor-1,4-phenylen bedeutet und der anderePh means 2- or 3-fluoro-1,4-phenylene and the other
Rest Ph 1,4-Phenylen bedeutet, sowie Biphenylylethane der Formel Ha, Radical Ph denotes 1,4-phenylene, and biphenylylethanes of the formula Ha,
worin R 1 und R2 die m Anspruch 1 angegebene Bedeutung haben. Die Verbindungen der Formel I werden nach an sich bekannten Methoden hergestellt, wie sie in der Literatur (z.B. in den Standardwerken wie Houben-Weyl, Methoden der Organischen Chemie, Georg-Thieme-Verlag, Stuttgart) beschrieben sind, und zwar unter Reaktionsbedingungen, die für die genannten Umsetzungen bekannt und geeignet sind. wherein R 1 and R 2 have the meaning given in claim 1. The compounds of the formula I are prepared by methods known per se, as described in the literature (for example in the standard works such as Houben-Weyl, Methods of Organic Chemistry, Georg-Thieme-Verlag, Stuttgart), and under reaction conditions that are known and suitable for the implementations mentioned.
Dabei kann man auch von an sich, bekannten, hier nicht näher erwähnten Varianten Gebrauch machen. Die Ausgangsstoffe können gewünschtenfalls auch in situ gebildet werden, derart, daß man sie aus dem Reaktionsgemisch nicht isoliert, sondern sofort weiter zu den It is also possible to use variants which are known per se and are not mentioned here in any more detail. If desired, the starting materials can also be formed in situ in such a way that they are not isolated from the reaction mixture, but instead are immediately passed on to the
Verbindungen der Formel I umsetzt. Reacts compounds of formula I.
So können die Verbindungen der Formel I hergestellt werden, indem man eine Verbindung der Formel II oder auch eine entsprechende Ethinverbindung Thus, the compounds of formula I can be prepared by using a compound of formula II or a corresponding ethyne compound
R3-X-Ph-Ph-CH=CH-Ph-Y-R4 II unter dem Fachmann bekannten Bedingungen katalytisch hydriert. In Formel II haben X, Y und Ph die oben R 3 -X-Ph-Ph-CH = CH-Ph-YR 4 II under the conditions known to the person catalytically hydrogenated. In Formula II, X, Y and Ph have the above
angegebenen Bedeutungen. R 3 und R4 bedeuten jewei indicated meanings. R 3 and R 4 each mean
unabhängig voneinander Alkyl oder Oxaalkyl. independently of one another alkyl or oxaalkyl.
Die Verbindungen der Formel II sind erhältlich in an sich bekannter Weise nach Wittig oder durch Heck-Kopplung aus entsprechenden Styrol-Verbindungen mit Halogenaromaten, welche entweder bekannt sind oder in völliger Analogie zu bekannten Verbindungen hergestellt werden können. The compounds of the formula II are obtainable in a manner known per se by Wittig or by Heck coupling from corresponding styrene compounds with halogen aromatics, which are either known or can be prepared in complete analogy to known compounds.
Ethine der Formel II können auch hergestellt werden über die Kopplung von Alkinyl-Zin-Verbindungen mit Arylhalo¬geniden analog dem von A.O. King, E. Negishi, F.J. Villani und A. Silveira in J. Org. Chem. 43 (1978) 358 beschriebenen Verfahren. Ethynes of the formula II can also be prepared via the coupling of alkynyl-zinc compounds with aryl halides analogously to that of A.O. King, E. Negishi, F.J. Villani and A. Silveira in J. Org. Chem. 43 (1978) 358.
Ethine der Formel II können auch über die Fritsch-Buttenberg-Wiechell-Umlagerung (Ann. 279, 319, 327, 332, 1984) hergestellt werden, bei der 1,1-Diaryl-2-halogenethylene umgelagert werden zu Diarylacetylenen in Gegenwart starker Basen. Ethine der Formel II können weiterhin hergestellt werden aus 4-substituierten Phenyl- oder Cyclohexylacetylenen und Arylhalogeniden in Gegenwart eines Palladiumkatalysators, z.B. Bis(triphenylphosphin)-palladium(II)-chlorid, und Kupfer(I)-jodid (beschrieben in Synthesis (1980) 627 oder Tetrahedron Letters 27 (1986) 1171). Ethynes of the formula II can also be prepared via the Fritsch-Buttenberg-Wiechell rearrangement (Ann. 279, 319, 327, 332, 1984), in which 1,1-diaryl-2-halogenethylenes are rearranged to diarylacetylenes in the presence of strong bases . Ethynes of the formula II can also be prepared from 4-substituted phenyl- or cyclohexylacetylenes and aryl halides in the presence of a palladium catalyst, for example bis (triphenylphosphine) palladium (II) chloride, and copper (I) iodide (described in Synthesis (1980) 627 or Tetrahedron Letters 27 (1986) 1171).
Erfindungsgemäße Verbindungen mit Alkenylgruppen lassen sich in Analogie zu ähnlichen, bekannten Verbindungen durch Wittig-Reaktion darstellen, wobei die Ausgangsmaterialien (entsprechend Formel I, jedoch einer der ResteCompounds according to the invention with alkenyl groups can be prepared in analogy to similar, known compounds by the Wittig reaction, the starting materials (corresponding to formula I, but one of the radicals
R1 und R2 ist -(CH2)x-CHO oder z.B. -(CH2)x-Br, X = 0 bis 5) in Analogie zu denoben beschriebenen Methoden zugänglich sind. R 1 and R 2 is - (CH 2 ) x -CHO or, for example, - (CH 2 ) x -Br, X = 0 to 5) in analogy to the methods described above.
Die Verbindungen der Formel I können weiterhin durch The compounds of formula I can continue to
Kreuzkopplungen nach DOS 36 08502, DOS 36 32 410 oder DOS 37 36489 oder durch Wolff-Kishner-Reduktion entsprechender Methylenketone hergestellt werden, die Cross couplings according to DOS 36 08502, DOS 36 32 410 or DOS 37 36489 or by Wolff-Kishner reduction of corresponding methylene ketones which are produced
ihrerseits aus den entsprechenden Arylessigsäurechloriden und entsprechenden Benzol- oder Biphenyl-Vorstufen in turn from the corresponding arylacetic acid chlorides and corresponding benzene or biphenyl precursors
zugänglich sind.  are accessible.
Die erfindungsgemäßen flüssigkristallinen Phasen bestehen aus 2 bis 15, vorzugsweise 3 bis 12 Komponenten, darunter mindestens einer Verbindung der Formel I. Die anderen Bestandteile werden vorzugsweise ausgewählt aus den nematischen oder nematogenen Substanzen, insbesondere den bekannten Substanzen, aus den Klassen der Azoxybenzole, Benzylidenaniline, Biphenyle, Terphenyle, Phenyl- oder Cyclohexylbenzoate, Cyclohexan-carbonsäurephenyl- oder -cyclohexyl-ester, Phenylcyclohexane, Cyclohexylbiphenyle, Cyclohexylcyclohexane, Cyclohexylnaphthaline, 1,4-Biscyclohexylbenzole, 4,4'-Bis-cyclohexylbiphenyle, Phenyloder Cyclophexylpyrimidine, Phenyl- oder Cyclohexyldioxane, Phenyl- oder Cyclohexyl-1,3-dithiane, 1,2-Diphenylethane, 1,2-Dicyclohexylethane, 1-Phenyl-2-cyclohexylethane, gegebenenfalls halogenierten Stilbene, The liquid-crystalline phases according to the invention consist of 2 to 15, preferably 3 to 12 components, including at least one compound of the formula I. The other constituents are preferably selected from the nematic or nematogenic substances, in particular the known substances, from the classes of the azoxybenzenes, benzylidene anilines, Biphenyls, terphenyls, phenyl or cyclohexyl benzoates, cyclohexane-carboxylic acid phenyl or cyclohexyl esters, phenylcyclohexanes, cyclohexyl biphenyls, Cyclohexylcyclohexanes, cyclohexylnaphthalenes, 1,4-biscyclohexylbenzenes, 4,4'-biscyclohexylbiphenyls, phenyl or cyclophexylpyrimidines, phenyl- or cyclohexyldioxanes, phenyl- or cyclohexyl-1,3-dithiane, 1,2-diphenylethanes, 1,2-dicyclohexyl 1-phenyl-2-cyclohexylethanes, optionally halogenated stilbenes,
Benzylphenylether und sübstituierten Zimtsäuren. Benzylphenyl ether and substituted cinnamic acids.
Die wichtigsten als Bestandteile derartiger flüssigkristalliner Phasen in Frage kommenden Verbindungen lassen sich durch die Formel IV charakterisieren, The most important compounds which are possible as constituents of such liquid-crystalline phases can be characterized by the formula IV,
R6-L-G-E-R7 IV worin L und E je ein carbo- oder heterocyclisches Ringsystem aus der aus 1,4-disubstituierten Benzol- und Cyclohexanringen, 4,4'-disubstituierten Biphenyl-, Phenylcyclohexan- und Cyclohexylcyclohexansystemen, 2,5-disubstituierten Pyrimidin- und 1,3-Dioxanringen, 2, 6-disubstituiertem Naphthalin, Di- und Tetrahydronaphthalin, R 6 -LGER 7 IV in which L and E each have a carbocyclic or heterocyclic ring system consisting of 1,4-disubstituted benzene and cyclohexane rings, 4,4'-disubstituted biphenyl, phenylcyclohexane and cyclohexylcyclohexane systems, 2,5-disubstituted pyrimidine - and 1,3-dioxane rings, 2, 6-disubstituted naphthalene, di- and tetrahydronaphthalene,
Chinazolin und Tetrahydrochinazolin gebildeten Gruppe, Quinazoline and tetrahydroquinazoline formed group,
G -CH=CH- -N(O)=N- -CH=CY- -CH=N(O)-G -CH = CH- -N (O) = N- -CH = CY- -CH = N (O) -
-C≡C- -CH2-CH2--C≡C- -CH 2 -CH 2 -
-CO-O- -CH2-O--CO-O- -CH 2 -O-
-CO-S- -CH2-S--CO-S- -CH 2 -S-
-CH=N- -COO-Phe-COO- oder eine C-C-Einfachbindung, -CH = N- -COO-Phe-COO- or a C-C single bond,
Y Halogen, vorzugsweise Chlor, oder -CN, und R6 und R7 Alkyl, Alkoxy, Alkanoyloxy oder Alkoxycarbonyloxy mit bis zu 18, vorzugsweise bis zu 8 Kohlenstoffatomen, oder einer dieser Reste durch CN, NC, NO2, CF3, F, Cl oder Br bedeuten Bei den meisten dieser Verbindungen sind R6 und R7 voneinander verschieden, wobei einer dieser Reste meist eine Alkyl- oder Alkoxygruppe ist. Auch auch andere Varianten der vorgesehenen Substituenten sind gebräuchlich. Viele solcher Substanzen oder auch Gemische davon sind im Handel erhältlich. Alle diese Substanzen sind nach literaturbekannten Methoden erhältlich. Y halogen, preferably chlorine, or -CN, and R 6 and R 7 denote alkyl, alkoxy, alkanoyloxy or alkoxycarbonyloxy having up to 18, preferably up to 8 carbon atoms, or one of these radicals by CN, NC, NO 2 , CF 3 , F, Cl or Br. Most of these compounds are R 6 and R 7 are different from one another, one of these radicals usually being an alkyl or alkoxy group. Other variants of the proposed substituents are also common. Many such substances or mixtures thereof are commercially available. All of these substances are obtainable by methods known from the literature.
Die erfindungsgemäßen Phasen enthalten etwa 0,1 bis 99 vorzugsweise 10 bis 95 %, einer oder mehrer Verbindungen der Formel I. Weiterhin bevorzugt sind erfindungsgemäße flüssigkristalline Phasen, enthaltend 0,1-40, vorzugsweise 0,5-30 % einer oder mehrerer Verbindungen der Formel I. The phases according to the invention contain about 0.1 to 99%, preferably 10 to 95%, of one or more compounds of the formula I. Also preferred are liquid-crystalline phases according to the invention, containing 0.1-40, preferably 0.5-30% of one or more compounds of Formula I.
Die Verbindungen der Formel I können auch als Komponenten smektischer oder chiral getuteter smektischer flüssigkristalliner Phasen verwendet werden. Diese Phasen sind bevorzugt chiral getutete smektische flüssigkristalline Phasen, deren achirale Basismischung neben Verbindungen der Formel I mindestens eine andere Komponente mit negativer oder betragsmäßig kleiner positiver dielektrischen Anisotropie enthält. Diese weitere(n) Komponente(n) der achiralen Basismischung kann (können) zu 1 bis 50 %, vorzugsweise 10 bis 25 %, der Basismischung ausmachen. The compounds of the formula I can also be used as components of smectic or chirally switched smectic liquid-crystalline phases. These phases are preferably chiral-chopped smectic liquid-crystalline phases, the achiral base mixture of which contains, in addition to compounds of the formula I, at least one other component with negative or small positive dielectric anisotropy. This further component (s) of the achiral base mixture can make up 1 to 50%, preferably 10 to 25%, of the base mixture.
Die Herstellung der erfindungsgemäßen Phasen erfolgt in an sich üblicher Weise. In der Regel werden die Komponenten ineinander gelöst, zweckmäßig bei erhöhter Temperatur. Durch geeignete Zusätze können die flüssigkristallinen Phasen nach der Erfindung so modifiziert werden, daß sie in allen bisher bekannt gewordenen Arten von Flüssigkristallanzeigeelementen verwendet werden können. Derartige Zusätze sind dem Fachmann bekannt und in der Literatur ausführlich beschrieben. Beispielsweise können Leitsalze, vorzugsweise Ethyl-dimethyl-dodecyl-ammonium-4-hexyloxybenzoat, Tetrabutylammonium-tetraphenylboranat oder Komplexsalze von Kronenethern (vg. z.B. I. Haller et al., Mol. Cryst. Liq. Cryst. Band 24, Seiten 249-258The phases according to the invention are produced in a conventional manner. As a rule, the components are dissolved in one another, expediently at elevated temperature. By means of suitable additives, the liquid-crystalline phases according to the invention can be modified so that they can be used in all types of liquid-crystal display elements which have hitherto become known. Such additives are known to the person skilled in the art and are described in detail in the literature. For example, conductive salts, preferably ethyl dimethyl dodecyl ammonium 4-hexyloxybenzoate, tetrabutylammonium tetraphenylboranate or complex salts of crown ethers (see, for example, I. Haller et al., Mol. Cryst. Liq. Cryst. Volume 24, pages 249-258
(1973)) zur Verbesserung der Leitfähigkeit, dichroitische Farbstoffe zur Herstellung farbiger Guest-Host-Systeme oder Substanzen zur Veränderung der dielektrischen Anisotropie, der Viskosität und/oder der Orientierung der nematischen Phasen zugesetzt werden. Derartige Substanzen sind z.B. in den DE-OS 22 09 127, 22 40 864, 23 21 632, 23 38 281, 24 50 088, 26 37 430, 28 53 728 und 29 02 177 beschrieben. (1973)) to improve the conductivity, dichroic dyes for producing colored guest-host systems or substances for changing the dielectric anisotropy, the viscosity and / or the orientation of the nematic phases are added. Such substances are e.g. in DE-OS 22 09 127, 22 40 864, 23 21 632, 23 38 281, 24 50 088, 26 37 430, 28 53 728 and 29 02 177.
Die folgenden Beispiele sollen die Erfindung erläutern, ohne sie zu begrenzen. F. = Schmelzpunkt, K. = Klärpunkt. Vor- und nachstehend bedeuten Prozentangaben Gewichtsprozent; alle Temperaturen sind in Grad Celsius angegeben. "Übliche Aufarbeitung" bedeutet: man gibt Wasser hinzu, extrahiert mit Methylenchlorid, trennt ab, trocknet die organische Phase, dampft ein und reinigt das Produkt durch Kristallisation und/oder Chromatographie. Beispiel 1 The following examples are intended to illustrate the invention without limiting it. F. = melting point, K. = clearing point. Percentages above and below mean percentages by weight; all temperatures are given in degrees Celsius. "Conventional work-up" means: water is added, the mixture is extracted with methylene chloride, the mixture is separated off, the organic phase is dried, evaporated and the product is purified by crystallization and / or chromatography. example 1
Eine Lösung von 10,6 g 1-(p-Ethoxyphenyl)-2-(4'-n-pentylbiphenyl-4-yl)-ethen [erhalten durch Heckkopplung von 4-Ethoxystyrol mit 4-Brom-4'-n-pentylbiphenyl] in 200 ml Tetrahydrofuran wird in Gegenwart von Pd/C bis zur Beendigung der H-Aufnähme hydriert. Nach üblicher Aufarbeitung erhält man 1-(p-Ethoxyphenyl)-2-(4'-n-pentylbiphenyl-4-yl)-ethan, F. 81°, K. 145° A solution of 10.6 g of 1- (p-ethoxyphenyl) -2- (4'-n-pentylbiphenyl-4-yl) ethene [obtained by rear coupling 4-ethoxystyrene with 4-bromo-4'-n-pentylbiphenyl ] in 200 ml of tetrahydrofuran is hydrogenated in the presence of Pd / C until the H uptake has ended. After customary working up, 1- (p-ethoxyphenyl) -2- (4'-n-pentylbiphenyl-4-yl) -ethane is obtained, mp 81 °, K. 145 °
Analog werden hergestellt: 1-(p-Methylphenyl)-2-(4'-n-propylbiphenyl-4-yl)-ethan, F 116° The following are prepared analogously: 1- (p-methylphenyl) -2- (4'-n-propylbiphenyl-4-yl) ethane, F 116 °
1-(p-Ethoxyphenyl)-2-(4'-ethylbiphenyl-4-yl)-ethan, 1- (p-ethoxyphenyl) -2- (4'-ethylbiphenyl-4-yl) ethane,
F. 114°, K. 136,5°  M. 114 °, K. 136.5 °
1-(p-Propylphenyl)-2-(4'-ethylbiphenyl-4-yl)-ethan,  1- (p-propylphenyl) -2- (4'-ethylbiphenyl-4-yl) ethane,
F. 77°, K. 121° F. 77 °, K. 121 °
1-(p-Propylphenyl)-2-(4'-pentylbiphenyl-4-yl)-ethan, 1- (p-propylphenyl) -2- (4'-pentylbiphenyl-4-yl) ethane,
F. 57°, K. 138° F. 57 °, K. 138 °
1-(p-Ethoxyphenyl)-2-(4'-butoxybiphenyl-4-yl)-ethan, 1- (p-ethoxyphenyl) -2- (4'-butoxybiphenyl-4-yl) ethane,
F. 133°, K. 176° F. 133 °, K. 176 °
1-(p-Methoxyphenyl)-2-(4'-pentylbiphenyl-4-yl)-ethan, 1- (p-methoxyphenyl) -2- (4'-pentylbiphenyl-4-yl) ethane,
F. 111°, K. 131° M. 111 °, K. 131 °
1-(p-Ethoxyphenyl)-2-(4'-propylbiphenyl-4-yl)-ethan, 1- (p-ethoxyphenyl) -2- (4'-propylbiphenyl-4-yl) ethane,
F. 94°, K. 148° M. 94 °, K. 148 °
1-(p-Butoxyphenyl)-2-(4'-pentylbiphenyl-4-yl)-ethan, F. 158° Beispiel 2 1- (p-butoxyphenyl) -2- (4'-pentylbiphenyl-4-yl) ethane, mp 158 ° Example 2
Eine Lösung von 1,9 g 1-(p-Ethoxyphenyl)-2-[4'-(trans-4-n-pentylcyclohexyl)-3'-fluorbiphenyl-4-yl]-ethen A solution of 1.9 g of 1- (p-ethoxyphenyl) -2- [4 '- (trans-4-n-pentylcyclohexyl) -3'-fluorobiphenyl-4-yl] ethene
[erhalten durch Heckkopplung von 4-Ethoxystyrol mit  [obtained by coupling 4-ethoxystyrene to the rear
4'-(trans-4-n-Pentylcyclohexyl)-3'-fluor-4-broιabiphenyl] in 50 ml Tetrahydrofuran wird in Gegenwart von Pd/C hydriert. Nach üblicher Aufarbeitung erhält man 1-(p- Ethoxyphenyl)-2-[4'-(trans-4-n-pentylcyclohexyl)-3'-fluorbiphenyl-4-yl)-ethan. Analog werden hergestellt: 4 '- (trans-4-n-pentylcyclohexyl) -3'-fluoro-4-broιabiphenyl] in 50 ml of tetrahydrofuran is hydrogenated in the presence of Pd / C. After customary working up, 1- (p-ethoxyphenyl) -2- [4 '- (trans-4-n-pentylcyclohexyl) -3'-fluorobiphenyl-4-yl) ethane is obtained. The following are produced analogously:
1-(p-Ethoxyphenyl)-2-(4'-ethoxy-3'-fluor-biphenyl-4-yl)-ethan, F. 133°, K. 155° 1- (p-ethoxyphenyl) -2- (4'-ethoxy-3'-fluoro-biphenyl-4-yl) ethane, mp 133 °, K. 155 °
Beispiel 3 Example 3
Eine Lösung von 3,2 g 1-(p-Ethylphenyl)-2-[4'-(trans-4-n-pentylcyclohexyl)-2'-fluorbiphenyl-4-yl]-ethen [erhalten durch Heckkopplung von p-Ethylstyrol mit 4'-(trans-4-n-Pentylcyclohexyl)-2'-fluor-4-brombiphenyl] in 100 ml Tetrahydrofuran wird in Gegenwart von Pd/C hydriert. A solution of 3.2 g of 1- (p-ethylphenyl) -2- [4 '- (trans-4-n-pentylcyclohexyl) -2'-fluorobiphenyl-4-yl] ethene [obtained by rear coupling of p-ethyl styrene with 4 '- (trans-4-n-pentylcyclohexyl) -2'-fluoro-4-bromobiphenyl] in 100 ml of tetrahydrofuran is hydrogenated in the presence of Pd / C.
Nach üblicher Aufarbeitung erhält man 1-(p-Ethylphenyl)-2-[4'-(txans-4-n-pentylcyclohexyl)-2'-fluorbiphenyl-4-yl)-ethan. After customary working up, 1- (p-ethylphenyl) -2- [4 '- (txans-4-n-pentylcyclohexyl) -2'-fluorobiphenyl-4-yl) ethane is obtained.
Analog werden hergestellt: The following are produced analogously:
1-(p-Methylphenyl)-2-[4'-(trans-4-ethylcyclohexyl)-2'-fluorbiphenyl-4-yl)-ethan 1- (p-Methylphenyl) -2- [4 '- (trans-4-ethylcyclohexyl) -2'-fluorobiphenyl-4-yl) ethane
1-(p-Ethylphenyl)-2-[4'-(trans-4-ethylcyclohexyl)-2'-fluorbiphenyl-4-yl)-ethan 1-(p-Propylphenyl)-2-[4'-(trans-4-ethylcyclohexyl)-2'-fluorbiphenyl-4-yl)-ethan 1- (p-ethylphenyl) -2- [4 '- (trans-4-ethylcyclohexyl) -2'-fluorobiphenyl-4-yl) ethane 1- (p-Propylphenyl) -2- [4 '- (trans-4-ethylcyclohexyl) -2'-fluorobiphenyl-4-yl) ethane
1-(p-Pentylphenyl)-2-[4'-(trans-4-ethylcyclohexyl)-2'-fluorbiphenyl-4-yl)-ethan 1-(p-Methylphenyl)-2-[4'-(trans-4-propylcyclohexyl)-2'-fluorbiphenyl-4-yl)-ethan  1- (p-pentylphenyl) -2- [4 '- (trans-4-ethylcyclohexyl) -2'-fluorobiphenyl-4-yl) ethane 1- (p-methylphenyl) -2- [4' - (trans- 4-propylcyclohexyl) -2'-fluorobiphenyl-4-yl) ethane
1-(p-Ethylphenyl)-2-[4'-(trans-4-propylcyclohexyl)-2'-fluorbiphenyl-4-yl)-ethan  1- (p-ethylphenyl) -2- [4 '- (trans-4-propylcyclohexyl) -2'-fluorobiphenyl-4-yl) ethane
1-(p-Propylphenyl)-2-[4'-(trans-4-propylcyclohexyl)-2'-fluorbiphenyl-4-yl)-ethan  1- (p-Propylphenyl) -2- [4 '- (trans-4-propylcyclohexyl) -2'-fluorobiphenyl-4-yl) ethane
1-(p-Pentylphenyl)-2-[4*-(trans-4-propylcyclohexyl)-2'-fluorbiphenyl-4-yl)-ethan  1- (p-pentylphenyl) -2- [4 * - (trans-4-propylcyclohexyl) -2'-fluorobiphenyl-4-yl) ethane
1-(p-Methylphenyl)-2-[4'-(trans-4-butylcyclohexyl)-2'-fluorbiphenyl-4-yl)-ethan 1- (p-methylphenyl) -2- [4 '- (trans-4-butylcyclohexyl) -2'-fluorobiphenyl-4-yl) ethane
1-(p-Ethylphenyl)-2-[4'-(trans-4-butylcyclohexyl)-2'-fluorbiphenyl-4-yl)-ethan 1- (p-ethylphenyl) -2- [4 '- (trans-4-butylcyclohexyl) -2'-fluorobiphenyl-4-yl) ethane
1-(p-Propylphenyl)-2-[4'-(trans-4-butylcyclohexyl)-2'-fluorbiphenyl-4-yl)-ethan  1- (p-Propylphenyl) -2- [4 '- (trans-4-butylcyclohexyl) -2'-fluorobiphenyl-4-yl) ethane
1-(p-Pentylphenyl)-2-[4'-(trans-4-butylcyclohexyl)-2'-fluorbiphenyl-4-yl)-ethan  1- (p-pentylphenyl) -2- [4 '- (trans-4-butylcyclohexyl) -2'-fluorobiphenyl-4-yl) ethane
1-(p-Methylphenyl)-2-[4'-(trans-4-pentylcyclohexyl)-2'- fluorbiphenyl-4-yl)-ethan 1- (p-methylphenyl) -2- [4 '- (trans-4-pentylcyclohexyl) -2'-fluorobiphenyl-4-yl) ethane
1-(p-Propylphenyl)-2-[4'-(trans-4-pentylcyclohexyl)-2'- fluorbiphenyl-4-yl)-ethan  1- (p-Propylphenyl) -2- [4 '- (trans-4-pentylcyclohexyl) -2'-fluorobiphenyl-4-yl) ethane
1-(p-Butylphenyl)-2-[4'-(trans-4-pentylcyclohexyl)-2'- fluorbiphenyl-4-yl)-ethan  1- (p-Butylphenyl) -2- [4 '- (trans-4-pentylcyclohexyl) -2'-fluorobiphenyl-4-yl) ethane
1-(p-Pentylphenyl)-2-[4'-(trans-4-ρentylcyclohexyl)-2'- fluorbiphenyl-4-yl)-ethan  1- (p-pentylphenyl) -2- [4 '- (trans-4-pentylcyclohexyl) -2'-fluorobiphenyl-4-yl) ethane
1-(p-Ethoxyphenyl)-2-[4'-(trans-4-pentylcyclohexyl)-2'- fluorbiphenyl-4-yl)-ethan, F. 69°, K. 229,4° B eispiel 4 1- (p-Ethoxyphenyl) -2- [4 '- (trans-4-pentylcyclohexyl) -2'-fluorobiphenyl-4-yl) ethane, mp 69 °, K. 229.4 ° Example 4
Eine Lösung von 1,2 g 1-(p-Ethylphenyl)-2-[4'-pentyl-2'-fluorbiphenyl-4-yl]-ethen [erhalten durch Heckkopplung von p-Ethylstyrol mit 4'-n-Pentyl-2'-fluor-4-brombiphenyl] in 50 ml Tetrahydrofuran wird in Gegenwart von Pd/C hydriert. Nach üblicher Aufarbeitung erhält man 1-(p-Ethylphenyl)-2-(4'-n-pentyl-2'-fluorbiphenyl-4-yl)-ethan. A solution of 1.2 g of 1- (p-ethylphenyl) -2- [4'-pentyl-2'-fluorobiphenyl-4-yl] ethene [obtained by rear coupling of p-ethylstyrene with 4'-n-pentyl- 2'-fluoro-4-bromobiphenyl] in 50 ml of tetrahydrofuran is hydrogenated in the presence of Pd / C. After the usual work-up, 1- (p-ethylphenyl) -2- (4'-n-pentyl-2'-fluorobiphenyl-4-yl) -ethane is obtained.
Analog werden hergestellt: The following are produced analogously:
1-(p-Ethylphenyl)-2-(4'-ethyl-2'-fluorbiphenyl-4-yl)-ethan 1-(p-Ethylphenyl)-2-(4'-propyl-2'-fluorbiphenyl-4-yl)-ethan 1-(p-Ethylphenyl)-2-(4'-butyl-2'-fluorbiphenyl-4-yl)-ethan 1-(p-Ethylphenyl)-2-(4'-heptyl-2'-fluorbiphenyl-4-yl)-ethan 1- (p-ethylphenyl) -2- (4'-ethyl-2'-fluorobiphenyl-4-yl) ethane 1- (p-ethylphenyl) -2- (4'-propyl-2'-fluorobiphenyl-4- yl) -ethane 1- (p-ethylphenyl) -2- (4'-butyl-2'-fluorobiphenyl-4-yl) -ethane 1- (p-ethylphenyl) -2- (4'-heptyl-2'- fluorobiphenyl-4-yl) ethane
1-(p-Methylphenyl)-2-(4'-ethyl-2'-fluorbiphenyl-4-yl)-ethan 1- (p-methylphenyl) -2- (4'-ethyl-2'-fluorobiphenyl-4-yl) ethane
1-(p-Methylphenyl)-2-(4'-propyl-2'-fluorbiphenyl-4-yl)-ethan, F. 65°, K. 66,3° 1- (p-methylphenyl) -2- (4'-propyl-2'-fluorobiphenyl-4-yl) ethane, mp 65 °, K. 66.3 °
1- (p-Methylphenyl ) -2- (4 ' -butyl-2 ' -fluorbiphenyl-4-yl )-ethan  1- (p-methylphenyl) -2- (4 'butyl-2' fluorobiphenyl-4-yl) ethane
1-(p-Methylphenyl)-2-(4'-pentyl-2'-fluorbiphenyl-4-yl)-ethan, F. 41°, K. 67,4°  1- (p-methylphenyl) -2- (4'-pentyl-2'-fluorobiphenyl-4-yl) ethane, mp 41 °, K. 67.4 °
1-(p-Methylphenyl)-2-(4'-heptyl-2'-fluorbiphenyl-4-yl)-ethan  1- (p-methylphenyl) -2- (4'-heptyl-2'-fluorobiphenyl-4-yl) ethane
1-(p-Methoxyphenyl)-2-(4'-ethyl-2'-fluorbiphenyl-4-yl)-ethan 1- (p-methoxyphenyl) -2- (4'-ethyl-2'-fluorobiphenyl-4-yl) ethane
1-(p-Methoxyphenyl)-2-(4'-propyl-2'-fluorbiphenyl-4-yl)- ethan 1- (p-methoxyphenyl) -2- (4'-propyl-2'-fluorobiphenyl-4-yl) ethane
1-(p-Methoxyphenyl)-2-(4'-butyl-2'-fluorbiphenyl-4-yl)-ethan 1-(p-Methoxyphenyl)-2-(4'-pentyl-2'-fluorbiphenyl-4-yl)-ethan, F. 49°, K. 87,5° 1- (p-methoxyphenyl) -2- (4'-butyl-2'-fluorobiphenyl-4-yl) ethane 1- (p-methoxyphenyl) -2- (4'-pentyl-2'-fluorobiphenyl-4-yl) ethane, mp 49 °, K. 87.5 °
1-(p-Methoxyphenyl)-2-(4'-heptyl-2'-fluorbiphenyl-4-yl)-ethan 1-(p-Propylphenyl)-2-(4'-ethyl-2'-fluorbiphenyl-4-yl)-ethan, F. 57°  1- (p-methoxyphenyl) -2- (4'-heptyl-2'-fluorobiphenyl-4-yl) ethane 1- (p-propylphenyl) -2- (4'-ethyl-2'-fluorobiphenyl-4- yl) -ethane, mp 57 °
1-(p-Propylphenyl)-2-(4'-propyl-2'-fluorbiphenyl-4-yl)-ethan, F. 52°, K. 60°  1- (p-propylphenyl) -2- (4'-propyl-2'-fluorobiphenyl-4-yl) ethane, mp 52 °, K. 60 °
1-(p-Propylphenyl)-2-(4'-butyl-2'-fluorbiphenyl-4-yl)-ethan  1- (p-propylphenyl) -2- (4'-butyl-2'-fluorobiphenyl-4-yl) ethane
1-(p-Propylphenyl)-2-(4'-pentyl-2'-fluorbiphenyl-4-yl)-ethan, F. 37°, K. 67', 5°  1- (p-propylphenyl) -2- (4'-pentyl-2'-fluorobiphenyl-4-yl) ethane, mp 37 °, K. 67 ', 5 °
1-(p-Propylphenyl)-2-(4'-heptyl-2'-fluorbiphenyl-4-yl)-ethan 1-(p-Butylphenyl)-2-(4'-ethyl-2'-fluorbiphenyl-4-yl)-ethan  1- (p-propylphenyl) -2- (4'-heptyl-2'-fluorobiphenyl-4-yl) ethane 1- (p-butylphenyl) -2- (4'-ethyl-2'-fluorobiphenyl-4- yl) -ethane
1-(p-Butylphenyl)-2-(4'-propyl-2'-fluorbiphenyl-4-yl)-ethan  1- (p-butylphenyl) -2- (4'-propyl-2'-fluorobiphenyl-4-yl) ethane
1-(p-Butylphenyl)-2-(4'-butyl-2'-fluorbiphenyl-4-yl)-ethan  1- (p-butylphenyl) -2- (4'-butyl-2'-fluorobiphenyl-4-yl) ethane
1-(p-Butylphenyl)-2-(4'-pentyl-2'-fluorbiphenyl-4-yl)-ethan  1- (p-butylphenyl) -2- (4'-pentyl-2'-fluorobiphenyl-4-yl) ethane
1-(p-Butylphenyl)-2-(4'-heptyl-2'-fluorbiphenyl-4-yl)- ethan 1-(p-Pentylphenyl)-2-(4l-ethyl-2'-fluorbiphenyl-4-yl)- ethan  1- (p-butylphenyl) -2- (4'-heptyl-2'-fluorobiphenyl-4-yl) ethane 1- (p-pentylphenyl) -2- (4l-ethyl-2'-fluorobiphenyl-4-yl ) - ethane
1-(p-Pentylphenyl)-2-(4'-propyl-2'-fluorbiphenyl-4-yl)- ethan, F. 40°, K. 67,7°  1- (p-pentylphenyl) -2- (4'-propyl-2'-fluorobiphenyl-4-yl) ethane, m.p. 40 °, K. 67.7 °
1-(p-Pentylphenyl)-2-(4'-butyl-2'-fluorbiphenyl-4-yl)- ethan 1-(p-Pentylphenyl)-2-(4'-pentyl-2'-fluorbiphenyl-4-yl)-ethan 1- (p-pentylphenyl) -2- (4'-butyl-2'-fluorobiphenyl-4-yl) ethane 1- (p-pentylphenyl) -2- (4'-pentyl-2'-fluorobiphenyl-4-yl) ethane
1-(p-Pentylphenyl)-2-(4'-heptyl-2'-fluorbiphenyl-4-yl)-ethan 1-(p-Heptylphenyl)-2-(4'-ethyl-2'-fluorbiphenyl-4-yl)-ethan  1- (p-pentylphenyl) -2- (4'-heptyl-2'-fluorobiphenyl-4-yl) ethane 1- (p-heptylphenyl) -2- (4'-ethyl-2'-fluorobiphenyl-4- yl) -ethane
1-(p-Heptylphenyl)-2-(4'-propyl-2'-fluorbiphenyl-4-yl)-ethan  1- (p-heptylphenyl) -2- (4'-propyl-2'-fluorobiphenyl-4-yl) ethane
1-(p-Heptylphenyl)-2 -(4'-butyl-2'-fluorbiphenyl-4-yl)-ethan  1- (p-heptylphenyl) -2 - (4'-butyl-2'-fluorobiphenyl-4-yl) ethane
1-(p-Heptylphenyl)-2 -(4'-pentyl-2'-fluorbiphenyl-4-yl)-ethan  1- (p-heptylphenyl) -2 - (4'-pentyl-2'-fluorobiphenyl-4-yl) ethane
1-(p-Heptylphenyl)-2 -(4'-heptyl-2'-fluorbiphenyl-4-yl)-ethan 1-(p-Propylphenyl)-2-(4'-ethyl-2-fluorbiphenyl-4-yl)-ethan  1- (p-heptylphenyl) -2 - (4'-heptyl-2'-fluorobiphenyl-4-yl) ethane 1- (p-propylphenyl) -2- (4'-ethyl-2-fluorobiphenyl-4-yl ) -ethane
1-(p-Propylphenyl)-2-(4'-propyl-2-fluorbiphenyl-4-yl)-ethan  1- (p-propylphenyl) -2- (4'-propyl-2-fluorobiphenyl-4-yl) ethane
1-(p-Propylphenyl)-2- (4'-butyl-2-fluorbiphenyl-4-yl)-ethan  1- (p-propylphenyl) -2- (4'-butyl-2-fluorobiphenyl-4-yl) ethane
1-(p-Propylphenyl)-2- (4'-pentyl-2-fluorbiphenyl-4-yl)-ethan  1- (p-propylphenyl) -2- (4'-pentyl-2-fluorobiphenyl-4-yl) ethane
1-(p-Propylphenyl)-2-(4'-heptyl-2-fluorbiphenyl-4-yl)-ethan  1- (p-propylphenyl) -2- (4'-heptyl-2-fluorobiphenyl-4-yl) ethane
1-(p-Propylphenyl)-2- (4'-propoxy-2-fluorbiphenyl-4-yl)-ethan 1- (p-propylphenyl) -2- (4'-propoxy-2-fluorobiphenyl-4-yl) ethane
1-(p-Pentylphenyl)-2-(4'-ethyl-2-fluorbiphenyl-4-yl)-ethan 1- (p-pentylphenyl) -2- (4'-ethyl-2-fluorobiphenyl-4-yl) ethane
1-(p-Pentylphenyl)-2-(4'-propyl-2-fluorbiphenyl-4-yl)-ethan  1- (p-pentylphenyl) -2- (4'-propyl-2-fluorobiphenyl-4-yl) ethane
1-(p-Pentylphenyl)-2-(4'-butyl-2-fluorbiphenyl-4-yl)-ethan 1-(p-Pentylphenyl)-2-(4'-pentyl-2-fluorbiphenyl-4-yl)-ethan 1- (p-pentylphenyl) -2- (4'-butyl-2-fluorobiphenyl-4-yl) ethane 1- (p-pentylphenyl) -2- (4'-pentyl-2-fluorobiphenyl-4-yl) ethane
1-(p-Pentylphenyl)-2-(4'-heptyl-2-fluorbiphenyl-4-yl)- ethan  1- (p-pentylphenyl) -2- (4'-heptyl-2-fluorobiphenyl-4-yl) ethane
1-(p-Pentylphenyl)-2-(4'-propoxy-2-fluorbiphenyl-4-yl)-ethan 1- (p-pentylphenyl) -2- (4'-propoxy-2-fluorobiphenyl-4-yl) ethane
1-(p-Methoxyphenyl)-2-(4'-ethyl-2-fluorbiphenyl-4-yl)-ethan 1- (p-methoxyphenyl) -2- (4'-ethyl-2-fluorobiphenyl-4-yl) ethane
1-(p-Methoxyphenyl)-2-(4'-propyl-2-fluorbiphenyl-4-yl)-ethan  1- (p-methoxyphenyl) -2- (4'-propyl-2-fluorobiphenyl-4-yl) ethane
1-(p-Methoxyphenyl)-2-(4'-butyl-2-fluorbiphenyl-4-yl)-ethan  1- (p-methoxyphenyl) -2- (4'-butyl-2-fluorobiphenyl-4-yl) ethane
1-(p-Methoxyphenyl)-2-(4'-pentyl-2-fluorbiphenyl-4-yl)-ethan  1- (p-methoxyphenyl) -2- (4'-pentyl-2-fluorobiphenyl-4-yl) ethane
1-(p-Methoxyphenyl)-2-(4'-heptyl-2-fluorbiphenyl-4-yl)-ethan 1- (p-methoxyphenyl) -2- (4'-heptyl-2-fluorobiphenyl-4-yl) ethane
1-(p-Methoxyphenyl)-2-(4'-propoxy-2-fluorbiphenyl-4-yl)-ethan  1- (p-methoxyphenyl) -2- (4'-propoxy-2-fluorobiphenyl-4-yl) ethane
1-(p-Propylphenyl)-2-(4'-ethyl-3-fluorbiphenyl-4-yl)-ethan 1- (p-propylphenyl) -2- (4'-ethyl-3-fluorobiphenyl-4-yl) ethane
1-(p-Propylphenyl)-2-(4'-propyl-3-fluorbipnenyl-4-yl)-ethan  1- (p-propylphenyl) -2- (4'-propyl-3-fluorobipnenyl-4-yl) ethane
1-(p-Propylphenyl)-2-(4'-pentyl-3-fluorbiphenyl-4-yl)- ethan  1- (p-propylphenyl) -2- (4'-pentyl-3-fluorobiphenyl-4-yl) ethane
1-(p-Propylphenyl)-2-(4'-heptyl-3-fluorbipbenyl-4-yl)- ethan  1- (p-propylphenyl) -2- (4'-heptyl-3-fluorobipbenyl-4-yl) ethane
1-(p-Propylphenyl)-2-(4'-propoxy-3-fluorbiphenyl-4-yl)- ethan  1- (p-propylphenyl) -2- (4'-propoxy-3-fluorobiphenyl-4-yl) ethane
1-(p-Methoxyphenyl)-2-(4'-ethyl-3-fluorbiphenyl-4-yl)- ethan 1- (p-methoxyphenyl) -2- (4'-ethyl-3-fluorobiphenyl-4-yl) ethane
1-(p-Methoxyphenyl)-2-(4'-propyl-3-fluorbiphenyl-4-yl)- ethan 1-(p-Methoxyphenyl)-2-(4'-pentyl-3-fluorbiphenyl-4-yl)-ethan 1- (p-methoxyphenyl) -2- (4'-propyl-3-fluorobiphenyl-4-yl) ethane 1- (p-methoxyphenyl) -2- (4'-pentyl-3-fluorobiphenyl-4-yl) ethane
1-(p-Methoxyphenyl)-2-(4'-heptyl-3-fluorbiphenyl-4-yl)-ethan  1- (p-methoxyphenyl) -2- (4'-heptyl-3-fluorobiphenyl-4-yl) ethane
1-(p-Methoxyphenyl)-2-(4'-propoxy-3-fluorbiphenyl-4-yl)-ethan 1- (p-methoxyphenyl) -2- (4'-propoxy-3-fluorobiphenyl-4-yl) ethane
1-(p-Propylphenyl)-2-(4'-ethoxy-2'-fluorbiphenyl-4-yl)-ethan 1- (p-propylphenyl) -2- (4'-ethoxy-2'-fluorobiphenyl-4-yl) ethane
1-(2-Fluor-4-propylphenyl)-2-(4'-ethylbiphenyl-4-yl)-ethan 1-(2-Fluor-4-propylphenyl)-2-(4'-propylbiphenyl-4-yl)-ethan 1-(2-Fluor-4-propylphenyl)-2-(4'-butylbiphenyl-4-yl)-ethan 1-(2-Fluor-4-propylphenyl)-2-(4'-pentylbiphenyl-4-yl)-ethan 1- (2-fluoro-4-propylphenyl) -2- (4'-ethylbiphenyl-4-yl) ethane 1- (2-fluoro-4-propylphenyl) -2- (4'-propylbiphenyl-4-yl) -ethane 1- (2-fluoro-4-propylphenyl) -2- (4'-butylbiphenyl-4-yl) -ethane 1- (2-fluoro-4-propylphenyl) -2- (4'-pentylbiphenyl-4- yl) -ethane
4,4-Bis-(p-Propylphenylethyl)-2-fluorbiphenyl 4,4-bis (p-propylphenylethyl) -2-fluorobiphenyl
4,4-Bis-(p-Ethylphenylethyl)-2-fluorbiphenyl 4,4-bis (p-ethylphenylethyl) -2-fluorobiphenyl
4,4-Bis-(p-Butylphenylethyl)-2-fluorbiphenyl 4,4-bis (p-butylphenylethyl) -2-fluorobiphenyl
4,4-Bis-(p-Pentylphenylethyl)-2-fluorbiphenyl 4,4-bis (p-pentylphenylethyl) -2-fluorobiphenyl

Claims

Patentansprüche 1. Biphenylylethane der Formel I, 1. Biphenylylethanes of formula I
R1-CH2-X-(CH2CH2)m-Ph-Ph-CH2CH2-Ph-Y-CH2-R2 worin R 1 und R2 jeweils unabhängig voneinander Alkyl, R 1 -CH 2 -X- (CH 2 CH 2 ) m -Ph-Ph-CH 2 CH 2 -Ph-Y-CH 2 -R 2 wherein R 1 and R 2 are each independently alkyl,
Alkenyl oder Oxaalkyl mit bis zu  Alkenyl or oxaalkyl with up to
12 C-Atomen, einer der Reste R 1 und R2 auch H, m 0 oder 1, X und Y jeweils unabhängig voneinander O, S, 12 carbon atoms, one of the radicals R 1 and R 2 also H, m 0 or 1, X and Y each independently of one another O, S,
CO-O, O-CO, O-CO-O oder eine Einfachbindung, Rest X auch 1,4-Phenylen oder trans-1,4-Cyclohexylen und Rest Y auch trans-1,4-Cyclohexylen, und Ph 1,4-Phenylen, einer oder zwei der Reste  CO-O, O-CO, O-CO-O or a single bond, radical X also 1,4-phenylene or trans-1,4-cyclohexylene and radical Y also trans-1,4-cyclohexylene, and Ph 1,4 -Phenylene, one or two of the residues
Ph auch 2- oder 3-Fluor-1,4-phenylen, bedeutet, mit der Maßgabe daß im Falle (a) X = 1,4-Phenylen und m = 1 einer oder zwei der Reste Ph 2- oder 3-Fluor- 1,4-phenylen bedeuten und (b) im Falle X = trans-1,4- Cyclohexylen, m = 0 und einer oder zwei der Reste Ph 2- oder 3-Fluor-1,4-phenylen bedeuten. Ph also means 2- or 3-fluoro-1,4-phenylene, with the proviso that in case (a) X = 1,4-phenylene and m = 1 one or two of the residues Ph 2- or 3-fluoro- 1,4-phenylene and (b) in the case of X = trans-1,4-cyclohexylene, m = 0 and one or two of the radicals Ph are 2- or 3-fluoro-1,4-phenylene.
2. Biphenylylethane nach Anspruch 1, gekennzeichnet durch die Formel II, 2. biphenylylethanes according to claim 1, characterized by the formula II,
worin R 1 und R2 die in Anspruch 1 angegebene Bedeutung haben, X 0 oder eine Einfachbindung ist, einer der Reste Ph 2- oder 3-Fluor-1,4-phenylen bedeutet und der andere Rest Ph 1,4-Phenylen bedeutet. wherein R 1 and R 2 have the meaning given in claim 1, X is 0 or a single bond, one of the radicals is Ph 2- or 3-fluoro-1,4-phenylene and the other radical is Ph 1,4-phenylene.
3. Biphenylylethane nach Anspruch 1, gekennzeichnet durch die Formel Ha, 3. biphenylylethane according to claim 1, characterized by the formula Ha,
worin R 1 und R2 die in Anspruch 1 angegebene Bedeutung haben. wherein R 1 and R 2 have the meaning given in claim 1.
4. Biphenylylethane nach Anspruch 1, gekennzeichnet durch die Formel I' : 4. Biphenylylethane according to claim 1, characterized by the formula I ':
R1-CH2-Ph-Ph-CH2CH2-Ph-CH2-R2 I' R 1 -CH 2 -Ph-Ph-CH 2 CH 2 -Ph-CH 2 -R 2 I '
5. Biphenylylethane nach Anspruch 1, gekennzeichnet durch die Formel I'': 5. Biphenylylethane according to claim 1, characterized by the formula I '':
6. Biphenylylethane nach Anspruch 1, gekennzeichnet durch die Formel I''' Biphenylylethane nach mindestens einem der Ansprüche 1 bis 6, dadurch gekennzeichnet, daß -Ph-Ph- 6. biphenylylethane according to claim 1, characterized by the formula I ''' Biphenylylethane according to at least one of Claims 1 to 6, characterized in that -Ph-Ph-
bedeutet. means.
8. Verwendung der Verbindungen der Formel I nach 8. Use of the compounds of formula I after
Anspruch 1 als Komponenten flüssigkristalliner  Claim 1 as components of liquid crystalline
Phasen.  Phases.
9. Flüssigkristalline Phase mit mindestens zwei flüssigkristallinen Komponenten, daduch gekennzeichnet, daß sie mindestens eine Verbindung der Formel I enthält. 9. Liquid-crystalline phase with at least two liquid-crystalline components, characterized in that it contains at least one compound of the formula I.
10. Flüssigkristallanzeigeelement, dadurch gekennzeichnet, daß es eine flüssigkristalline Phase nach Anspruch 9 enthält. 10. Liquid crystal display element, characterized in that it contains a liquid crystalline phase according to claim 9.
EP90903347A 1989-01-27 1990-01-22 Diphenylethanes Withdrawn EP0407569A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3902327 1989-01-27
DE3902327 1989-01-27
DE3913164 1989-04-21
DE3913164A DE3913164C2 (en) 1989-01-27 1989-04-21 Biphenylylethanes and their use for the production of liquid crystalline phases

Publications (1)

Publication Number Publication Date
EP0407569A1 true EP0407569A1 (en) 1991-01-16

Family

ID=25877169

Family Applications (1)

Application Number Title Priority Date Filing Date
EP90903347A Withdrawn EP0407569A1 (en) 1989-01-27 1990-01-22 Diphenylethanes

Country Status (5)

Country Link
US (1) US5093026A (en)
EP (1) EP0407569A1 (en)
JP (1) JPH03503651A (en)
CA (1) CA2026112A1 (en)
WO (1) WO1990008756A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7449249B2 (en) 2004-09-17 2008-11-11 Sulzer Metco Ag Spray powder
US8709384B2 (en) 2005-05-09 2014-04-29 Biosphere Medical, S.A. Compositions and methods using microspheres and non-ionic contrast agents
US8741351B2 (en) 2000-03-24 2014-06-03 Biosphere Medical, Inc. Microspheres for active embolization

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH089565B2 (en) * 1989-07-20 1996-01-31 三洋化成工業株式会社 Liquid crystal compound
EP0450368A3 (en) * 1990-03-31 1992-03-18 Merck Patent Gesellschaft Mit Beschraenkter Haftung Liquid crystal display and liquid crystal mixture
WO1991015555A2 (en) * 1990-04-02 1991-10-17 MERCK Patent Gesellschaft mit beschränkter Haftung Nematic liquid crystal mixtures and a matrix liquid crystal display
JP6488623B2 (en) 2014-02-25 2019-03-27 Jnc株式会社 Liquid crystal composition and liquid crystal display element
JP6476693B2 (en) * 2014-02-26 2019-03-06 Jnc株式会社 Liquid crystal composition and liquid crystal display element
JP6677122B2 (en) * 2015-08-20 2020-04-08 Jnc株式会社 Compound having alkenyl at both ends, liquid crystal composition and liquid crystal display device

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0084194B1 (en) * 1982-01-14 1986-04-30 MERCK PATENT GmbH Liquid crystal mixtures
EP0167912B1 (en) * 1984-07-12 1990-01-03 F. Hoffmann-La Roche Ag Liquid crystal mixtures containing compounds with a 4-alkenyl or 2z-alkenyl lateral chain
US4621091A (en) * 1984-10-09 1986-11-04 Merck & Co., Inc. 3-hydroxybenzo[b]thiophene-2-sulfide derivatives compositions, and method of use therefor
DE3441937A1 (en) * 1984-11-16 1986-05-28 Bayer Ag, 5090 Leverkusen LIQUID CRYSTAL MATERIAL
EP0263843B1 (en) * 1986-02-21 1992-12-02 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Liquid crystal compounds, mixtures and devices
DE3733818A1 (en) * 1987-10-07 1989-04-20 Merck Patent Gmbh FERROELECTRIC LIQUID CRYSTALLINE PHASES
IT1232356B (en) * 1988-03-10 1992-01-28 Merck Patent Gmbh DIALOGENOBENZOL-DERIVATIVES

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9008756A1 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8741351B2 (en) 2000-03-24 2014-06-03 Biosphere Medical, Inc. Microspheres for active embolization
US7449249B2 (en) 2004-09-17 2008-11-11 Sulzer Metco Ag Spray powder
US8709384B2 (en) 2005-05-09 2014-04-29 Biosphere Medical, S.A. Compositions and methods using microspheres and non-ionic contrast agents

Also Published As

Publication number Publication date
US5093026A (en) 1992-03-03
JPH03503651A (en) 1991-08-15
WO1990008756A1 (en) 1990-08-09
CA2026112A1 (en) 1990-07-28

Similar Documents

Publication Publication Date Title
EP0149208B1 (en) Ethane derivatives
EP0281611B1 (en) Liquid crystal phases for electro-optic display elements based on the ecb effect
EP0264435B1 (en) Smectic liquid crystal phases
EP0306505B1 (en) Acetylene derivatives as components of liquid crystal phases
EP0308438B1 (en) Liquid crystal phase containing tolanes
EP0357727B1 (en) 2,3-difluorobenzene derivatives and their use as components of liquid crystal media
DE3333677A1 (en) LIQUID CRYSTAL PHASE
DE3604462A1 (en) Smectic liquid crystal phases
DD274233A5 (en) LIQUID CRYSTALLINE COMPOSITION CONTAINING GLUORIZED OLIGOPHENYLE
EP0151446A2 (en) Liquid crystal phase
EP0429558B1 (en) Diphenylylethanes and liquid crystalline phase
EP0407569A1 (en) Diphenylethanes
EP0226592B1 (en) Liquid crystal phase
WO1988009322A1 (en) Cyclobutane derivatives
DE3902328A1 (en) Biphenylylethanes
DE3837208A1 (en) Naphthylacetylenes
DE3913164C2 (en) Biphenylylethanes and their use for the production of liquid crystalline phases
DE3443929A1 (en) CARBONITRILE
DE3734517C2 (en) Acetylenes and liquid-crystalline phases containing them
DD243937A5 (en) LIQUID CRYSTALLINE PHASE CONTAINING CYCLOHEXANDERIVATE
DE3711306A1 (en) Tolan derivatives, and use of carbonitriles in liquid-crystalline phases for display elements based on the ECB effect
DE4338348B4 (en) 2,6-Disubstituted benzotrifluorides
DE3913554A1 (en) New bi:phenylyl:ethane cpds. - for use in liq. crystal phases having large optical anisotropy and increased stability
DE3905932A1 (en) Tolan derivatives
DE3717397A1 (en) Cyclohexene derivatives

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE ES FR GB IT LI LU NL SE

17P Request for examination filed

Effective date: 19901220

17Q First examination report despatched

Effective date: 19920825

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19930305